However, a controversy has started a year, or more, before the vaccine will be ready for the public. In the hopes of heading off a confrontation, officials from the developing companies -- Merck & Co. and GlaxoSmithKline -- are meeting with advocacy groups to try to relieve their concerns. Merck is creating the drug to be used on 11 ? 26 year old women.
"The guidelines state that routine vaccination with Gardasil is recommended for 11- and 12-year-old females and for females ages 13 to 26 who have not previously been vaccinated or who have not completed the full series, and that vaccination with Gardasil can be started at nine years of age," Merck said in a news release.
The American Medical Women's Association recommends that doctors check all women 30 years and older for the human papillomavirus, or HPV, that may cause the cancer. The 14,000-member group is also lobbying insurance companies to pay for the vaccine.
The group is planning on re-directing attention to the benefits of new tools to fight cervical cancer, which has a kill rate of 230,000 women annually. The association is taking a stand in favor of the vaccine. A politically volatile topic -- HPV can be transmitted through sexual contact.
"We wanted to reaffirm that girls really do need access to this vaccine," said Dr. Susan Ivey,the association's president and an adjunct associate professor at UC Berkeley's School of Public Health. "We wanted to frame the discussion in a public-health context, where what you really want is to make your population resistant to diseases and one way to do that is through vaccination."
The American Medical Women's Association is the first non-government body to recommend routine vaccination for young girls. Doctors say the vaccine is most effective when given before sexual activity starts.
The vaccine targets four strains of human papillomavirus. Many women carry HPV through their entire lifetimes, but most women are able to fight off an infections before they ever realize they have the virus.
Beyond the vaccine, the American Women's Medical Association is advocating wider use of a relatively new test that goes beyond the standard Pap smear that typically is used to check women for cervical cancer.
Christine Baze 38, underwent surgery and radiation and chemotherapy to treat an advanced case of cervical cancer. She hope the vaccine and HPV test will help a hundreds of women avoid her suffering.
"It's incredible the tools that are available to prevent cancer now," she said. "I just don't want anybody to have to go through what I went through ... and the good news is, they don't have to. We have an amazing opportunity to eliminate this cancer."
While the idea of a mandatory vaccine for a sexually transmitted disease has ignited a worldwide moral debate, the release of the drug was approved in the USA in June 2006. At the moment, Canada is the only country actively proposing the vaccine for both boys and girls as it causes a cosmetic blemish when given to boys.
Prof. Kevin Ault, Gynaecologist, from the EmoryUniversity School of Medicine, University ofIowa, USA has present the results of the lastStudy's conclusions are Incredible and it's true;he told about a vaccine, that is 100 % effectivein preventing the most common types of Cervicalcancer linked to HPV (D3-to see).
The HPV infections are sexually transmitteddiseases which prepare the way for cervicalcancer. We can protect the women against the mostCarcinogenic subtypes (6, 11, 16 and 18 of HPV)which are the cause of More than 70 % of cervicalcancers.
With optimistic results of the Future II study,20541 Women from Europe, America and Asia,between the ages of 16 and 26 years old, wasinvolved in this extensive project. Of course,the methodological rules, as a blind Studycompared the quadrivalent vaccine do a placebo.The Vaccine protected the young women completelyagainst precancerous Lesions (medium - orhigh-grad) of the Cervix related to HPV 16 and18. The protection result was 100 % of cases! Thesid-effects comes with an extremely low number.If we see the large number of cases in thisstudy, the results should be the same ifvaccination is made Available to the public.
We should not forget - the Cervical Cancer is thesecond leading cancer in Young women and accountsfor 11 % of Cancers in all women! When the Womenhas a common genital Infection with the humanpapillomavirus (HPV) and its can result in theappearance of precancerous lesions of the CervixMucous membrane. For instance, we know that theconnection between HPV infection and cervicalcancer is much stronger than that between smokingand lung cancer.
How the researcher has got these results? Withthis new quadrivalent vaccine for cervicalcancer, the most oncogenic subtypes of HPV cannow be whipped out. One of the first steps isvaccinating adolescents (D3-“Chronical”) Beforethey come into contact with the virus; - Results- No virus, no Lesions - no cancer! Prevention -the essential part of the combating CervicalCancer.
The most oncogenic subtypes of HPV can now bewiped out thanks to this new quadrivalentvaccine. The first step is vaccinatingadolescents (D3 - “Chronical”) before they comeinto contact with the virus; this is a turningpoint in the fight against cancer. It is a majortool in the prevention of precancerous lesions inthe cervix. No virus, no lesions - and if thereare no lesions, that means no cancer. Preventionis an essential part of the equation when itcomes to combating cervical cancer - that's whyoncologists are so excited about the new Vaccine.
A study conducted with more than 20,000 women hasshown the absolute effectiveness of a vaccine inthe prevention of cervical cancer due to the mostcommon types of human papillomavirus (HPV).Oncologists are enthusiastic. It is a rare thingto hear physicians - and even more so,oncologists -get excited to the point of speakingof a “historical breakthrough” after hearing apresentation from a colleague.
Prof. Thomas Turz, Director of the InstituteGustave Roussy at the ECCO conference has say -It is a rare thing to hear physicians - and evenmore so, oncologists -get excited to the point ofspeaking of a “historical breakthrough” afterhearing a presentation from a colleague. TheOncologists are enthusiastic.
Both Ethan Miller & Fritz Frei are contributors for EditorialToday. The above articles have been edited for relevancy and timeliness. All write-ups, reviews, tips and guides published by EditorialToday.com and its partners or affiliates are for informational purposes only. They should not be used for any legal or any other type of advice. We do not endorse any author, contributor, writer or article posted by our team.
Ethan Miller has sinced written about articles on various topics from Heart Conditions, Mind Power and High Cholesterol. Ethan Miller advises on improving your heath and reducing pain from his web site at http://www.acnescarsmagic.com He invites you to get his FREE health guide http://www.acnerescue.com. Ethan Miller's top article generates over 6600 views. to your Favourites.
Fritz Frei has sinced written about articles on various topics from Travel and Leisure, Woman Menopause and Types of Cancer. Fritz Frei make it easy to check out the important details about the diagnoses and test's of the Male - Breast-Cancer. To receive more information's about all cancer -questions - Links and last research NEW's - visit the. Fritz Frei's top article generates over 165000 views. to your Favourites.